Clinical Trial Update: Addition of Efavirenz or Nelfinavir to a Lamivudine/Zidovudine/Indinavir HIV Treatment Regimen [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating whether adding efavirenz or nelfinavir to a lamivudine/zidovudine/indinavir regimen improves HIV treatment outcomes; the study has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Crixivan (indinavir)
• Epivir (Lamivudine)
• RETROVIR (Zidovudine)
• Sustiva (efavirenz)
• Viracept (Nelfinavir)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 3 | Status: COMPLETED